Success Stories: An Indian Staff Scientist in Neuroscience Obtains NIW Approval Without RFE, Retains NAILG for EB1-A Petition, and Gets Another Approval
Client’s Testimonial:
“Thank you for your assistance.”
On October 1st, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: Staff Scientist
Country of Origin: India
State of Residence at the Time of Filing: Missouri
Approval Notice Date: October 1st, 2022
Processing Time: 8 months, 14 days
Case Summary:
The USCIS has set clear rules for qualifying under various categories of immigrant and nonimmigrant visas for foreign nationals. So is the case with the I-140 NIW or National Interest Waiver visa of the nonimmigrant type. The regulation says that only those individuals who can prove that their work is of some benefit to the nation, can and will be allowed to qualify under this category. So when we got an expert in Neuroscience from India who needed our help with his petition, we ensured the success of his case by picking details from his academic and professional experience. Some of these are as follows:
- Details of his proposed endeavor: As an expert in the field of neuroscience, the client’s proposed endeavor was to build on his extensive experience with protein aggregation, disease modeling systems, medicinal chemistry, and disease mechanisms to investigate the structure of amyloid aggregates in order to develop non-invasive methods for the diagnosis of neurodegenerative diseases.
- Importance of his work for the country, industry, and the world: His research was of great importance because it provided substantial knowledge of pathologic protein aggregation mechanisms and aims to develop non-invasive diagnosis methods for neurodegenerative diseases. His work has identified a number of therapeutic targets that are fundamental to the development of treatments for these severe diseases. His proposed endeavor also has broad implications for the United States, since neurodegenerative diseases have become an enormous healthcare and economic burden to the United States.
- Funding Information: It is due to its clear national importance, that his research has in fact been supported with funding from the National Institutes of Health, the National Science Foundation, the BrightFocus Foundation, the Mary E. Groff Charitable Trust, the American Parkinson Disease Association, the ALS Association, and the Michael J. Fox Foundation.
- Peer Reviews, Publications, and Citations: He has also actively participated in peer review service and has completed at least 23 reviews to date. Along with this, his research has resulted in 12 peer-reviewed journal articles (2 of them first-authored) and 1 accepted article which has been cited a total of 370 times according to Google Scholar.
- Experience and Letters of Recommendation: Not only this 9 years of research in the area have not gone unnoticed by other experts who corroborated the information from our client’s documents with their letters of recommendation. Our team added 2 such letters to aid the case’s adjudication.